Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Transition Bio Closes $50M Series A Financing

2023-06-10
CAMBRIDGE, MA, Transition Bio, Inc., a microfluidics-driven drug discovery platform, announced its $50 million Series A financing, led by Northpond Ventures.
Transition Bio, Inc., a microfluidics-driven drug discovery platform company using biophysical sciences and artificial intelligence tools to map and modulate biomolecular condensates, announced its $50 million Series A financing, led by Northpond Ventures and joined by Taiho Ventures, Bristol Myers Squibb and Magnetic Ventures. Lifeforce Capital, the lead investor from the Company's seed financing, also participated and was joined by other existing seed investors.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors